Literature DB >> 8494332

Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.

J J Kepes1.   

Abstract

Thirty-one patients with large, focal cerebral demyelinating lesions are reported. Twenty-four patients had solitary lesions and 7 had multiple foci, the latter apparently of identical age. The lesions presented clinically and radiologically as brain tumors (gliomas or metastases) or as multiple cysts. Six patients were older than 57 years (2 in their 70s) at the onset of their symptoms. The demyelinating nature of the lesions was established through biopsy in each patient and all improved significantly after corticosteroid therapy. Three patients developed additional lesions during the follow-up periods ranging from 9 months to 12 years consistent with the course of multiple sclerosis. Twenty-eight patients did not develop additional lesions. These included 6 patients with multiple lesions at the onset. In 1 of the patients, the first symptoms developed 10 days after receiving vaccination against influenza. Two patients had concomitant malignancy (chronic monomyelogenous leukemia and retroperitoneal seminoma respectively) and 1 patient developed immunoblastic sarcoma in the opposite hemisphere after biopsy diagnosis and steroid treatment of her demyelinating lesion. Tumor-like masses of demyelination may occupy an intermediate position between multiple sclerosis and postinfectious/postvaccination encephalitis. The clinical course (history of vaccination in one instance, acute onset, good response to corticosteroids, no clinical or radiological evidence of new lesions in the great majority of patients) favored postinfectious/postvaccination encephalitis. Lesion size however greatly exceeded that of the small foci of perivenous demyelination seen in typical postinfectious/postvaccination encephalitis and tended to present as space-occupying masses.

Entities:  

Mesh:

Year:  1993        PMID: 8494332     DOI: 10.1002/ana.410330105

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  57 in total

1.  Childhood multiple sclerosis and related disorders.

Authors:  Amna Al-Futaisi
Journal:  Oman Med J       Date:  2007-10

2.  Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour.

Authors:  A Häne; M Bargetzi; E Hewer; M Bruehlmeier; A Khamis; U Roelcke
Journal:  J Neurol       Date:  2010-08-29       Impact factor: 4.849

3.  Negative association of Epstein-Barr virus or herpes simplex virus-1 with tumefactive central nervous system inflammatory demyelinating disease.

Authors:  Takao Kiriyama; Hiroshi Kataoka; Takahiko Kasai; Akitaka Nonomura; Satoshi Ueno
Journal:  J Neurovirol       Date:  2010-11-11       Impact factor: 2.643

4.  Primary CNS demyelinating diseases in childhood: multiple sclerosis.

Authors:  P Iannetti; M G Marciani; A Spalice; F Spanedda; U Raucci; G Trasimeni; G F Gualdi; G Bernardi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

5.  Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging.

Authors:  M Ricci; P Pantano; A Pierallini; D Di Stefano; A Santoro; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1996-05

Review 6.  Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?

Authors:  R C Dale; J A Branson
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

Review 7.  Tumefactive demyelinating lesions: nine cases and a review of the literature.

Authors:  Lei Xia; Song Lin; Zhong-cheng Wang; Shao-wu Li; Li Xu; Jing Wu; Shu-yu Hao; Chuan-chuan Gao
Journal:  Neurosurg Rev       Date:  2009-01-27       Impact factor: 3.042

Review 8.  Demyelinating diseases.

Authors:  S Love
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 9.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

10.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.